Ipsen SA

Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC

07 дек 2023 00:00:00 Источник Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 45 - 2023

14 ноя 2023 11:00:00 Источник Nasdaq GlobeNewswire

Results from Ipsen’s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine

13 ноя 2023 15:30:00 Источник Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 44 - 2023

07 ноя 2023 11:00:00 Источник Nasdaq GlobeNewswire

Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital

06 ноя 2023 11:00:00 Источник Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 43 - 2023

31 окт 2023 12:00:00 Источник Nasdaq GlobeNewswire

Ipsen delivers solid sales growth in the first nine months of 2023 and confirms its full-year guidance

26 окт 2023 00:00:00 Источник Nasdaq GlobeNewswire

IPSEN - Buy-back program - Art 5 of MAR - Week 42 - 2023

24 окт 2023 11:00:00 Источник Nasdaq GlobeNewswire

Ipsen updates on E.U. Marketing Authorisation Application for odevixibat in Alagille syndrome

23 окт 2023 00:00:00 Источник Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 41 - 2023

17 окт 2023 11:00:00 Источник Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 40 - 2023

10 окт 2023 11:00:00 Источник Nasdaq GlobeNewswire

Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital

06 окт 2023 11:00:00 Источник Nasdaq GlobeNewswire

Ipsen updates on QM-1114 regulatory process

03 окт 2023 11:00:00 Источник Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2023

03 окт 2023 11:00:00 Источник Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 38 - 2023

26 сен 2023 11:00:00 Источник Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 37 - 2023

19 сен 2023 11:00:00 Источник Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 36 - 2023

12 сен 2023 11:00:00 Источник Nasdaq GlobeNewswire

Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital

08 сен 2023 11:00:00 Источник Nasdaq GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 35 - 2023

05 сен 2023 11:00:00 Источник Nasdaq GlobeNewswire

Ipsen nominates Pascal Touchon to its Board of Directors as new independent director

04 сен 2023 00:00:00 Источник Nasdaq GlobeNewswire